Lack of Benefit of Treating Helicobacter pylori Infection in Patients with Functional Dyspepsia. Randomized One-year Follow-up Study

Hepato-Gastroenterology

Volumn 51, Issue 55, 2004, Pages 303-308

  Gisbert, Javier P ^a,b   Cruzado, Ana Isabel ^a   Garcia Gravalos, Rafael ^a   Pajares, Jose Maria ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b NONE   (Spain)

Author keywords

Eradication; Functional dyspepsia; Helicobacter pylori; Non ulcer dyspepsia; Treatment

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE; RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPEPSIA; EPIGASTRIC PAIN; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOM; TREATMENT FAILURE; UREA BREATH TEST; VOMITING;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; RANITIDINE; TREATMENT FAILURE;

EID: 10744223322     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Talley NJ, Silverstein MD, Agreus L, Nyren O, Sonnenberg A, Holtmann G: AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998; 114:582-595.
2. McNamara DA, Buckley M, O'Morain CA: Nonulcer dyspepsia. Current concepts and management. In: Gastroenterol Clin North Am. Helicobacter pylori. Part II. Philadelphia: WB Saunders, 2000; pp. 807-818.
3. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN: Functional gastroduodenal disorders. Gut 1999; 45(Suppl 2):1137-1142.
4. Veldhuyzen van Zanten SJ, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR: Design of treatment trials for functional gastrointestinal disorders. Gut 1999; 45(Suppl 2):1169-1177.
5. Working Party of the European Helicobacter pylori Study Group: Guidelines for clinical trials in Helicobacter pylori infection. Gut 1997; 41(Suppl 2):S1-9.
6. Veldhuyzen van Zanten SJ, Tytgat KM, Pollak PT, Goldie J, Goodacre RL, Riddell RH, et al: Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis? J Clin Epidemiol 1993; 46:273-279.
7. Sheu BS, Lin CY, Lin XZ, Shiesh SC, Yang HB, Chen CY: Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: a prospective controlled assessment. Am J Gastroenterol 1996; 91:441-447.
8. McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, et al: Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998; 339:1869-1874.
9. Blum AL, Talley NJ, O'Morain C, van Zanten SV, Labenz J, Stolte M, et al: Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med 1998; 339:1875-1881.
10. Greenberg PD, Cello JP: Lack of effect of treatment for Helicobacter pylori on symptoms of nonulcer dyspepsia. Arch Intern Med 1999; 159:2283-2288.
11. Dhali GK, Garg PK, Sharma MP: Role of anti-Helicobacter pylori treatment in H. pylori-positive and cytoprotective drugs in H. pylori-negative, non-ulcer dyspepsia: results of a randomized, double-blind, controlled trial in Asian Indians. J Gastroenterol Hepatol 1999; 14:523-528.
12. Talley NJ, Vakil N, Ballard ED, 2nd, Fennerty MB: Absence of benefit of eradicating Helicobocter pylori in patients with nonulcer dyspepsia. N Engl J Med 1999; 341:1106-1111.
13. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E: Eradication of Helicobocter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. BMJ 1999; 318:833-837.
14. Miwa H, Hirai S, Nagahara A, Murai T, Nishira T, Kikuchi S, et al: Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study. Aliment Pharmacol Ther 2000; 14:317-324.
15. Buckley M, O'Morain C: Prevalence of Helicobacter pylori in non-ulcer dyspepsia. Aliment Pharmacol Ther 1995; 9:53-58.
16. Armstrong D: Helicobacter pylori infection and dyspepsia. Scand J Gastroenterol Suppl 1996; 215:38-47.
17. Talley NJ, Xia HH: Helicobacter pylori infection and non-ulcer dyspepsia. Br Med Bull 1998; 54:63-69.
18. Jaakkimainen RL, Boyle E, Tudiver F: Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis. BMJ 1999; 319:1040-1044.
19. Talley NJ, Hunt RH: What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H: pylori being associated with dyspeptic symptoms. Gastroenterology 1997; 113:S67-77.
20. Laheij RJ, Jansen JB, van de Lisdonk EH, Severens JL, Verbeek AL: Review article: symptom improvement through eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 1996; 10:843-850.
21. Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, et al: Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ 2000; 321:659-664.
22. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, et al: Eradication of Helicobacter pylori for non-ulcer dyspepsia (Cochrane review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2001.
23. Veldhuyzen van Zanten SJ, Sherman PM: Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ 1994; 150:177-185.
24. Laine L, Schoenfeld P, Fennerty MB: Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001; 134:361-369.
25. Gibinski K: Step by step towards the natural history of peptic ulcer disease. J Clin Gastroenterol 1983; 5:299-302.
26. Gisbert JP, Pajares JM: Helicobacter pylori 'test-and-treat' strategy for dyspeptic patients. Scand J Gastroenterol 1999; 34:644-652.
27. Veldhuyzen van Zantent SJO: Dyspepsia is no indication for Helicobacter pylori eradication. In: RH Hunt, GNJ Tytgat (Eds.). Helicobacter pylori. Basic Mechanisms to Clinical Cure. Dordrech: Kluwer Academic Publishers 2000; pp. 435-441.
28. Parsonnet J: The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9:45-51.
29. Tan AC, Hartog GD, Mulder CJ: Eradication of Helicobacter pylori does not decrease the long-term use of acid-suppressive medication. Aliment Pharmacol Ther 1999; 13:1519-1522.
30. Verdu EF, Armstrong D, Fraser R, Viani F, Idstrom JP, Cederberg C, et al: Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995; 36:539-543.
31. Talley NJ: A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994; 106:1174-1183.
32. Veldhuyzen van Zanten SJ, Cleary C, Talley NJ, Peterson TC, Nyren O, Bradley LA, et al: Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996; 91:660-673.
33. Valle J, Seppala K, Sipponen P, Kosunen T: Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand J Gastroenterol 1991; 26:1057-1065.